SSA
TTOO

Schonfeld Strategic Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6
Closed -$39K – 2197
2020
Q4 		$39K Buy
+6
New +$36.7K ﹤0.01% 1506
2019
Q3 		– Sell
-3
Closed -$29K – 1294
2019
Q2 		$29K Buy
+3
New +$35.1K ﹤0.01% 947
2019
Q1 		– Sell
-21
Closed -$321K – 1350
2018
Q4 		$321K Sell
21
-44
-68% -$1.03M 0.01% 809
2018
Q3 		$2.4M Buy
+65
New +$2.14M 0.11% 254

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Schonfeld Strategic Advisors's TTOO Position: Q1 2021 in Review

Schonfeld Strategic Advisors sold out of T2 Biosystems, Inc (TTOO) in Q1 2021, closing a stake of 6 shares — an estimated $39K sold.

Schonfeld Strategic Advisors first reported a position in TTOO in Q3 2018 and held it in 4 quarters. The position peaked at $2.4M in Q3 2018. 73 funds tracked by Wall St. Rank hold TTOO as of Q1 2021.

  • Schonfeld Strategic Advisors reported no remaining T2 Biosystems, Inc position as of Q1 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 6 T2 Biosystems, Inc shares in Q1 2021, an estimated $39K.
  • Schonfeld Strategic Advisors first reported a position in T2 Biosystems, Inc in Q3 2018 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's T2 Biosystems, Inc position peaked at $2.4M in Q3 2018.
  • 73 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.